Regulation of alternative splicing and polyadenylation in cancer, therapeutic modulation of RNA processing, antisense technology development, induction of natural antagonists of oncogenes, manipulation of Receptor Tyrosine Kinase (e.g. EGFR, VEGFR, MET, etc.) and STAT3 signaling pathways in cancer.
Program Faculty
- Luca Cartegni
- Associate Professor
- Department: Department of Chemical Biology
- Graduate Program(s): Cellular and Molecular Pharmacology
- Major Research Interest(s): Cancer Biology, Signaling
- Research Organism(s): Cell lines
- Phone: 1.8484458018
- Email:
This email address is being protected from spambots. You need JavaScript enabled to view it. - Ernest Mario School of Pharmacy
- Susan L. Cullman Laboratory for Cancer Research
- 164 Frelinghuysen Road
- Piscataway, NJ 08854-0789
- Key Words: Regulation of alternative splicing and polyadenylation in cancer